Surface acoustic waves increase the susceptibility of Pseudomonas aeruginosa biofilms to antibiotic treatment

Biofouling

Volumn 27, Issue 7, 2011, Pages 701-711

  Kopel, Moran ^a   Degtyar, Elena ^a   Banin, Ehud ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Antibiotics; Biofilm; Surface acoustic waves; Transcriptome analysis

Indexed keywords

ACOUSTIC WAVE; ANTIBIOTICS; BACTERIUM; BIOFILM; FREQUENCY ANALYSIS; HEALTH RISK; SPECIES DIVERSITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79960284333     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2011.597051     Document Type: Article

References (43)

1. Balasubramanian D, Mathee K. 2009. Comparative transcriptome analyses of Pseudomonas aeruginosa. Hum Genom 3:349-361.
2. Banin E, Brady KM, Greenberg EP. 2006. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72:2064-2069.
3. Branda SS, Vik S, Friedman L, Kolter R. 2005. Biofilms: the matrix revisited. Trends Microbiol 13:20-26.
4. Brown DFJ, Brown L. 1991. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J Antimicrob Chemother 27:185-190.
5. Bryers JD. 2008. Medical biofilms. Biotechnol Bioeng 100: 1-18.
6. Cao L, Srikumar R, Poole K. 2004. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol Microbiol 53:1423-1436.
7. Carmen JC, Nelson JL, Beckstead BL, Runyan CM, Robison RA, Schaalje GB, Pitt WG. 2004a. Ultrasonicenhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J Infect Chemother 10:193-199.
8. Carmen JC, Roeder BL, Nelson JL, Ogilvie RL, Robison RA, Schaalje GB, Pitt WG. 2005. Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control 33:78-82.
9. Carmen JC, Roeder BL, Nelson JL, Beckstead BL, Runyan CM, Schaalje GB, Robison RA, Pitt WG. 2004b. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl 18:237-245.
10. Cornelis P. 2010. Iron uptake and metabolism in pseudomonads. Appl Microbiol Biotechnol 86:1637-1645.
11. Cowell BA, Twining SS, Hobden JA, Kwong MS, Fleiszig SM. 2003. Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 149:2291-2299.
12. Daigle DM, Cao L, Fraud S, Wilke MS, Pacey A, Klinoski R, Strynadka NC, Dean CR, Poole K. 2007. Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa. J Bacteriol 189: 5441-5451.
13. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114-122.
14. del Pozo JL, Patel R. 2007. The challenge of treating biofilmassociated bacterial infections. Clin Pharmacol Ther 82:204-209.
15. Donlan RM. 2008. Biofilms on central venous catheters: is eradication possible? Curr Top Microbiol Immunol 322:133-161.
16. Girshevitz O, Nitzan Y, Sukenik CN. 2008. Solutiondeposited amorphous titanium dioxide on silicone rubber: a conformal, crack-free antibacterial coating. Chem Mater 20:1390-1396.
17. Glick R, Gilmour C, Tremblay J, Satanower S, Avidan O, Deziel E, Greenberg EP, Poole K, Banin E. 2010. Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol 192: 2973-2980.
18. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell Microbiol 11:1034-1043.
19. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95-108.
20. Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7:654-665.
21. Hazan Z, Zumeris J, Jacob H, Raskin H, Kratysh G, Vishnia M, Dror N, Barliya T, Mandel M, Lavie G. 2006. Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves. Antimicrob Agents Chemother 50:4144-4152.
22. Hoiby N, Ciofu O, Bjarnsholt T. 2010. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5:1663-1674.
23. Holloway BW, Krishnapillai V, Morgan AF. 1979. Chromosomal genetics of Pseudomonas. Microbiol Rev 43: 73-102.
24. Kim K, Kim YU, Koh BH, Hwang SS, Kim SH, Lepine F, Cho YH, Lee GR. 2010. HHQ and PQS, two Pseudomonas aeruginosa quorum-sensing molecules, down-regulate the innate immune responses through the nuclear factor-kappaB pathway. Immunology 129:578-588.
25. Lewis K. 2010. Persister cells. Annu Rev Microbiol 64: 357-372.
26. Lopez D, Vlamakis H, Kolter R. 2010. Biofilms. Cold Spring Harb Perspect Biol 2:a000398.
27. Macfarlane EL, Kwasnicka A, Hancock RE. 2000. Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
28. McPhee JB, Lewenza S, Hancock RE. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50:205-217.
29. Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K. 2009. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health 2: 101-111.
30. Parkins MD, Ceri H, Storey DG. 2001. Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation. Mol Microbiol 40:1215-1226.
31. Petrova OE, Sauer K. 2010. The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA. J Bacteriol 192:5275-5288.
32. Pitt WG, Ross SA. 2003. Ultrasound increases the rate of bacterial cell growth. Biotechnol Prog 19:1038-1044.
33. Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li XZ, Nishino T. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol 21:713-724.
34. Qian Z, Sagers RD, Pitt WG. 1999. Investigation of the mechanism of the bioacoustic effect. J Biomed Mater Res 44:198-205.
35. Rediske AM, Rapoport N, Pitt WG. 1999a. Reducing bacterial resistance to antibiotics with ultrasound. Lett Appl Microbiol 28:81-84.
36. Rediske AM, Hymas WC, Wilkinson R, Pitt WG. 1998. Ultrasonic enhancement of antibiotic action on several species of bacteria. J Gen Appl Microbiol 44: 283-288.
37. Rediske AM, Roeder BL, Nelson JL, Robison RL, Schaalje GB, Robison RA, Pitt WG. 2000. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 44:771-772.
38. Rediske AM, Roeder BL, Brown MK, Nelson JL, Robison RL, Draper DO, Schaalje GB, Robison RA, Pitt WG. 1999b. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother 43:1211-1214.
39. Ryder C, Byrd M, Wozniak DJ. 2007. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 10:644-648.
40. Sanchez P, Rojo F, Martinez JL. 2002. Transcriptional regulation of mexR, the repressor of Pseudomonas aeruginosa mexAB-oprM multidrug efflux pump. FEMS Microbiol Lett 207:63-68.
41. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
42. Van Alst NE, Picardo KF, Iglewski BH, Haidaris CG. 2007. Nitrate sensing and metabolism modulate motility, biofilm formation, and virulence in Pseudomonas aeruginosa. Infect Immun 75:3780-3790.
43. Wilderman PJ, Vasil AI, Johnson Z, Wilson MJ, Cunliffe HE, Lamont IL, Vasil ML. 2001. Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect Immun 69:5385-5394.